We are investigating whether metformin can improve liver blood flow in patients with cirrhosis and portal hypertension. This study will also assess the safety of metformin and its effects on liver health.
Health conditions and diseases that the clinical trial is designed to study and treat.
Portal Hypertension is a condition characterized by increased blood pressure in the portal vein, which can lead to serious complications, especially in patients with cirrhosis. It often results from liver diseases and can cause symptoms like swelling in the abdomen, varices, and gastrointestinal bleeding.
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.